NEVRO CORP - Common Stock, par value $0.001 per share (NVRO)

Historical Holders from Q4 2014 to Q1 2025

Symbol
NVRO on NYSE
CUSIP
64157F103
Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
37.6M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
36M
Holdings value
$134M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
126
Number of buys
65
Number of sells
-67
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of NEVRO CORP - Common Stock, par value $0.001 per share (NVRO)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ARMISTICE CAPITAL, LLC 9.97% $21.8M 3.74M Armistice Capital, LLC Dec 31, 2024
Beryl Capital Management LLC 6.5% $14.3M 2.44M Beryl Capital Management LLC Mar 3, 2025
Shay Capital LLC 4.19% $9.18M 1.57M Shay Capital LLC Dec 31, 2024

Institutional Holders of NEVRO CORP - Common Stock, par value $0.001 per share (NVRO)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 117K $682K -$2.3M $5.84 7
2024 Q4 36M $134M -$14.1M $3.72 126
2024 Q3 37.6M $210M +$5.47M $5.59 130
2024 Q2 37.3M $314M -$7.41M $8.42 152
2024 Q1 37.2M $538M -$21.4M $14.44 150
2023 Q4 38.3M $823M +$70.2M $21.52 139
2023 Q3 34.8M $670M -$1.23M $19.22 135
2023 Q2 34.4M $876M -$45.7M $25.42 152
2023 Q1 35.4M $1.28B -$99.1M $36.15 157
2022 Q4 38M $1.51B +$61.5M $39.60 166
2022 Q3 33M $1.54B -$21.3M $46.60 167
2022 Q2 33.4M $1.46B -$109M $43.83 170
2022 Q1 35.9M $2.6B -$65M $72.33 186
2021 Q4 35.5M $2.88B -$77.4M $81.07 196
2021 Q3 37.1M $4.32B -$173M $116.38 186
2021 Q2 38.4M $6.36B +$165M $165.79 201
2021 Q1 37.4M $5.21B +$135M $139.50 197
2020 Q4 36.1M $6.25B +$97.2M $173.10 217
2020 Q3 35.7M $4.97B -$147M $139.30 204
2020 Q2 37M $4.43B +$446M $119.47 194
2020 Q1 33.4M $3.34B +$76.4M $99.98 176
2019 Q4 32.4M $3.81B -$21.5M $117.54 185
2019 Q3 32.2M $2.77B -$59.7M $85.97 149
2019 Q2 33.3M $2.16B +$300M $64.83 153
2019 Q1 32M $2B +$59.8M $62.51 167
2018 Q4 30.9M $1.2B -$139M $38.89 151
2018 Q3 31.8M $1.81B -$185M $57.00 165
2018 Q2 33.5M $2.68B +$76.9M $79.85 186
2018 Q1 32.7M $2.83B +$28.9M $86.67 191
2017 Q4 32M $2.21B -$54.4M $69.04 189
2017 Q3 32.7M $2.97B +$66.3M $90.88 181
2017 Q2 31.9M $2.37B +$171M $74.43 195
2017 Q1 29.7M $2.78B +$209M $93.70 189
2016 Q4 29M $2.1B +$22.6M $72.66 169
2016 Q3 28.1M $2.94B -$23.3M $104.39 187
2016 Q2 28.6M $2.11B +$97.1M $73.76 169
2016 Q1 27.5M $1.55B +$198M $56.26 135
2015 Q4 24.1M $1.62B +$117M $67.51 124
2015 Q3 22.5M $1.04B +$203M $46.39 106
2015 Q2 17.6M $941M +$460M $53.75 108
2015 Q1 11.3M $541M +$20.4M $47.93 75
2014 Q4 11.3M $436M +$348M $38.67 70